Louisiana Reclassifies Drugs Used in Abortions as Controlled Dangerous Substances - KFF Health News
Louisiana has reclassified mifepristone and misoprostol, drugs used in abortions, as Schedule IV controlled substances, effective immediately. This imposes new registration, recordkeeping, and reporting requirements on pharmacies and prescribers.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on July 28, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Critical. All pharmacies (independent, retail chain, compounding, long-term-care) and prescribers in Louisiana that handle mifepristone or misoprostol. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediately; enforcement begins upon publication.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Mifepristone and misoprostol are now Schedule IV controlled substances under Louisiana law, requiring DEA registration, secure storage, PDMP reporting, and prescription limits.
Who it affects
All pharmacies (independent, retail chain, compounding, long-term-care) and prescribers in Louisiana that handle mifepristone or misoprostol.
What you must do
Ensure pharmacy is registered with DEA for Schedule IV; update inventory and dispensing procedures; report to PDMP; verify prescriptions comply with new limits.
Deadline
Immediately; enforcement begins upon publication.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- Pharmacy technicians must register with Florida's Board of Pharmacy by Jan. 1, 2010 - Drug Topics
- Judge Trims DEA's Suspension Of Fla. Pharmacy's Permits - Law360
- New Wisconsin Law Regulates PBM and Other Stakeholders Involved in Drug Pricing - Quarles
- Pharmacists in WV can now give COVID-19 vaccines without prescriptions - Charleston Gazette-Mail
- What Does DEA’s Proposed Special Registration Framework for Tele-prescribing Controlled Substances Mean? - Reed Smith LLP